A company’s plan to edit the genomes of human embryos worries some researchers — but it might reflect the changing attitudes towards the controversial approach.
Pairwise has licensed its Fulcrum® gene editing platform to the International Rice Research Institute (IRRI), a non-profit agricultural research organization. The agreement will enable IRRI to apply ...
Caribou Biosciences shares rose after its CAR-T therapies showed high response rates and durable remissions in lymphoma and myeloma trials.
Through cutting-edge methods and advanced artificial intelligence analysis, UNC Charlotte researchers leading a ...
NEW DELHI (AP) — The U.S. government will stop sharing air quality data gathered from its embassies and consulates, worrying local scientists and experts who say the effort was vital to monitor global ...
Two days after Intellia voluntarily paused dosing due to safety concerns, the regulator stepped in with an official hold that ...
Gene editing techniques, including CRISPR, prime editing, and nucleases, allow scientists to tackle genetic diseases, cancer, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results